Researchers who re-ran a crucial fungicide study on neurotoxicity have come up with significantly different findings, and campaigners argue that the substance should now be withdrawn from the market.
In 2005, a study conducted by Huntingdon Life Sciences on behalf of ISK, the manufacturer of fluazinam, on the development of neurotoxicity of fluazinam in pregnant rats concluded there were no statistically significant effects in relation to brain development in the rats’ offspring.
